VADs), it is not surprising that bleeding and thrombosis are among the most common and
feared complications of this therapy, respectively. Although strides have been made in our …

Chronic oral anticoagulation frequently requires interruption for various reasons and
durations. Whether or not to bridge with heparin or other anticoagulants is a common clinical …

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

CO-CHAIRS: Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia
Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of …

Continuous-flow left ventricular assist devices (LVAD) have emerged as the standard of care
for advanced heart failure patients requiring long-term mechanical circulatory support …

Objectives: The aim of this study was to determine whether results with the HeartMate (HM) II
left ventricular assist device (LVAD)(Thoratec Corporation, Pleasanton, California) in a …

Background—The HeartMate II (HMII) destination therapy (DT) trial demonstrated significant
improvements in outcomes in continuous-flow left ventricular assist devices compared with …

Durable left ventricular assist devices (LVADs) have not only enhanced longevity but also
conferred sustained improvements in quality of life, symptom control, and functional capacity …

Objectives We review differences in the incidence and timing of adverse events in patients
implanted with continuous-flow left ventricular assist devices (LVADs), using the Mechanical …

Abstract The 2011 Canadian Cardiovascular Society Heart Failure (HF) Guidelines Focused
Update reviews the recently published clinical trials that will potentially impact on …